Results 11 to 20 of about 54,283 (258)

Changing Pattern of Visceral Leishmaniasis, United Kingdom, 1985-2004 [PDF]

Emerging Infectious Diseases, 2006
A 20-year (1985–2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed.
Aeesha N.J. Malik, Lawrence John, Anthony D.M. Bryceson, Diana N.J. Lockwood   +3 more
doaj   +7 more sources

Burden of visceral leishmaniasis in villages of eastern gedaref state, Sudan: an exhaustive cross-sectional survey. [PDF]

, 2012
Since December 2009, Médecins Sans Frontières has diagnosed and treated patients with visceral leishmaniasis (VL) in Tabarak Allah Hospital, eastern Gedaref State, one of the main endemic foci of VL in Sudan.
A Ismail, A Stauch, AB Joshi, AM Musa, B Bucheton, CP Thakur, Dagemlidet Worku, DE Elnaiem, DE Elnaiem, EA Khalil, EE Zijlstra, EE Zijlstra, EE Zijlstra, EE Zijlstra, F Chappuis, Fabienne Nackers, François Chappuis, GK Adam, H Veeken, Hechmi Louzir, Himida Ali Gorashi, Jean-Claude Djoumessi, Jean-François Etard, JH Kolaczinski, K Ritmeijer, K Ritmeijer, K Ritmeijer, Khalid A. Ahmed, Koert Ritmeijer, Marleen Boelaert, Niven Salih, OF Osman, Omer Hammam, Rahma Eltigani, SE Meredith, Y Mueller, Yolanda Kathrin Mueller, ZM Luz   +37 more
core   +28 more sources

Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity

Microorganisms, 2021
Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers.
John M. Curtin, Naomi E. Aronson
doaj   +1 more source

Leishmaniasis: new approaches to disease control. [PDF]

, 2003
The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L, Davies, Clive R, Kaye, Paul, Sundar, Shyam   +3 more
core   +2 more sources

Visceral Leishmaniasis in Dogs [PDF]

Acta Scientiae Veterinariae, 2021
Background: Canine visceral leishmaniasis (CVL) is a zoonosis of variable clinical presentation, either in systemic or cutaneous form. Clinical signs include anorexia, ophthalmopathies, and chronic kidney disease. In the state of Santa Catarina, the foci are concentrated in the capital and its adjacencies, in the east side of the state.
Silveira, Nathalia Saynovich Dutra, Mendes, Eduarda Mariana, Pereira, Marcy Lancia, Tavela, Alexandre de Oliveira, Veiga, Angela Patricia Medeiros, Zimermann, Francielli Cordeiro   +5 more
openaire   +2 more sources

Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. [PDF]

, 2007
During an epidemic of visceral leishmaniasis (VL) in eastern Sudan, Médecins Sans Frontières distributed 357,000 insecticide-treated bednets (ITN) to 155 affected villages between May 1999 and March 2001.
Alten, Bern, Bern, Curtis, El-Safi, Elnaiem, Elnaiem, Elnaiem, Elnaiem, Elnaiem, Giha, Graham, Hassan, Khalil, Lambert, Lengeler, Pardo, Reyburn, Ritmeijer, Schorscher, Tayeh, Zijlstra, Zijlstra   +22 more
core   +2 more sources

Visceral Leishmaniasis

Infectious Disease Clinics of North America, 2012
Diagnostic advances in visceral leishmaniasis include the development of the rK39 and rK28 rapid diagnostic test. The direct agglutination test is also increasingly used, as well as conventional and real-time polymerase chain reaction, which also performs well on peripheral blood.
van Griensven, J., Diro, E.
openaire   +6 more sources

ANÁLISE DOS FATORES QUE INFLUENCIAM A OCORRÊNCIA DA LEISHMANIOSE VISCERAL HUMANA

Cogitare Enfermagem, 2021
Objective: to analyze the factors that influence the occurrence of Human Visceral Leishmaniasis in the state of Paraíba, Brazil. Methods: ecological study, developed with data from 2012 to 2017, collected in a reference laboratory in the state and in the
Allan Batista Silva, Francisca Inês de Sousa Freitas, Clélia de Alencar Xavier Mota, Maria Eliane Moreira Freire, Hemílio Fernandes Campos Coêlho, Caliandra Maria Bezerra Luna Lima   +5 more
doaj   +1 more source

Treatment of visceral leishmaniasis

Journal of Global Infectious Diseases, 2010
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, adverse effects and cost, making treatment a complex issue. We review the evidence relating to the different methods of treatment in relation to - efficacy and toxicity of the drugs in different areas of the world; ability to monitor side effects, length
Diana N. J. Lockwood, EM Moore
openaire   +4 more sources

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. [PDF]

, 2011
Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human ...
Aderie, Endashaw Mengistu, Chane, Solomon, Collin, Simon M, Davidson, Robert N, Piening, Turid, Ritmeijer, Koert, ter Horst, Rachel   +6 more
core   +2 more sources